[ad_1] Pharma major Lupin on Saturday, September 28, said the United States Food and Drug Administration (USFDA) has issued three observations each on the API and finished product side of its Pithampur facility. The USFDA inspected the facility from September 16 to September 27. The pharma company said it is addressing the observations comprehensively and […]
Headline
Tag: usfda observations for lupin
Back To Top